{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:10:34Z","timestamp":1794111034558,"version":"4.8.0"},"reference-count":82,"publisher":"European Respiratory Society (ERS)","issue":"163","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2021,11,13]]},"published-print":{"date-parts":[[2022,3,31]]},"abstract":"<jats:p>Sarcoidosis-associated pulmonary hypertension (SAPH) is an important complication of advanced sarcoidosis. Over the past few years, there have been several studies dealing with screening, diagnosis and treatment of SAPH. This includes the results of two large SAPH-specific registries. A task force was established by the World Association of Sarcoidosis and Other Granulomatous disease (WASOG) to summarise the current level of knowledge in the area and provide guidance for the management of patients. A group of sarcoidosis and pulmonary hypertension experts participated in this task force. The committee developed a consensus regarding initial screening including who should undergo more specific testing with echocardiogram. Based on the results, the committee agreed upon who should undergo right-heart catheterisation and how to interpret the results. The committee felt there was no specific phenotype of a SAPH patient in whom pulmonary hypertension-specific therapy could be definitively recommended. They recommended that treatment decisions be made jointly with a sarcoidosis and pulmonary hypertension expert. The committee recognised that there were significant defects in the current knowledge regarding SAPH, but felt the statement would be useful in directing future studies.<\/jats:p>","DOI":"10.1183\/16000617.0165-2021","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T15:10:44Z","timestamp":1644419444000},"page":"210165","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension"],"prefix":"10.1183","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-8975","authenticated-orcid":false,"given":"Laurent","family":"Savale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Shlobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Kouranos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiliaro","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Al-Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athol U","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"2024102404005680000_31.163.210165.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.07.008"},{"key":"2024102404005680000_31.163.210165.2","doi-asserted-by":"crossref","first-page":"105997","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir Med"},{"key":"2024102404005680000_31.163.210165.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00897-2019"},{"key":"2024102404005680000_31.163.210165.4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-94-007-4546-9_38","article-title":"Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience","volume":"755","author":"Pabst","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"2024102404005680000_31.163.210165.5","first-page":"36","article-title":"Pulmonary hypertension in patients with sarcoidosis: a single-center experience","volume":"25","author":"Ozen","year":"2021","journal-title":"Anatol J Cardiol"},{"key":"2024102404005680000_31.163.210165.6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.5.1246"},{"key":"2024102404005680000_31.163.210165.7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2018.12.012","article-title":"The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension \u2013 a cohort study","volume":"199","author":"Tiosano","year":"2019","journal-title":"Clin Immunol"},{"key":"2024102404005680000_31.163.210165.8","first-page":"82","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: a single centre retrospective experience using targeted therapies","volume":"31","author":"Keir","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00175907"},{"key":"2024102404005680000_31.163.210165.10","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1737.62471"},{"key":"2024102404005680000_31.163.210165.11","first-page":"121","article-title":"Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study","volume":"64","author":"Rizzato","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"2024102404005680000_31.163.210165.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1483"},{"key":"2024102404005680000_31.163.210165.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2546"},{"key":"2024102404005680000_31.163.210165.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2002"},{"key":"2024102404005680000_31.163.210165.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00083404"},{"key":"2024102404005680000_31.163.210165.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.11.576"},{"key":"2024102404005680000_31.163.210165.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2016"},{"key":"2024102404005680000_31.163.210165.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00221-2018"},{"key":"2024102404005680000_31.163.210165.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.3.922"},{"key":"2024102404005680000_31.163.210165.20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2018.04.015","article-title":"Clinical features of sarcoidosis associated pulmonary hypertension: results of a multi-national registry","volume":"139","author":"Baughman","year":"2018","journal-title":"Respir Med"},{"key":"2024102404005680000_31.163.210165.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00465-2017"},{"key":"2024102404005680000_31.163.210165.22","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41598-019-40030-w","article-title":"Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension","volume":"9","author":"Parikh","year":"2019","journal-title":"Sci Rep"},{"key":"2024102404005680000_31.163.210165.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.09.031"},{"key":"2024102404005680000_31.163.210165.24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01747-2019"},{"key":"2024102404005680000_31.163.210165.25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.042838"},{"key":"2024102404005680000_31.163.210165.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.3.873"},{"key":"2024102404005680000_31.163.210165.27","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2514"},{"key":"2024102404005680000_31.163.210165.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0324"},{"key":"2024102404005680000_31.163.210165.29","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.134429"},{"key":"2024102404005680000_31.163.210165.30","first-page":"352","article-title":"The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?","volume":"34","author":"Tandon","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.31","first-page":"108","article-title":"Pulmonary hypertension in sarcoidosis","volume":"23","author":"Baughman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.32","doi-asserted-by":"crossref","first-page":"e1800","DOI":"10.1097\/MD.0000000000001800","article-title":"Pulmonary hypertension complicating fibrosing mediastinitis","volume":"94","author":"Seferian","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2024102404005680000_31.163.210165.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2007.12.006"},{"key":"2024102404005680000_31.163.210165.34","doi-asserted-by":"publisher","DOI":"10.1159\/000243786"},{"key":"2024102404005680000_31.163.210165.35","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/crj.12435","article-title":"Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension","volume":"11:","author":"Liu","year":"2015","journal-title":"Clin Respir J"},{"key":"2024102404005680000_31.163.210165.36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01290-2016"},{"key":"2024102404005680000_31.163.210165.37","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1513\/AnnalsATS.201902-119CME","article-title":"Update in cardiac sarcoidosis","volume":"16","author":"Ribeiro Neto","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404005680000_31.163.210165.38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"2024102404005680000_31.163.210165.39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.acvd.2016.12.014","article-title":"Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors","volume":"110","author":"Chapelon-Abric","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"2024102404005680000_31.163.210165.40","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1140"},{"key":"2024102404005680000_31.163.210165.41","doi-asserted-by":"publisher","DOI":"10.1378\/chest.76.5.536"},{"key":"2024102404005680000_31.163.210165.42","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.12-1524","article-title":"Excessive daytime sleepiness and obstructive sleep apnea in patients with sarcoidosis","volume":"143","author":"Patterson","year":"2013","journal-title":"Chest"},{"key":"2024102404005680000_31.163.210165.43","doi-asserted-by":"publisher","DOI":"10.1159\/000029523"},{"key":"2024102404005680000_31.163.210165.44","first-page":"61","article-title":"Sleep apnea in sarcoidosis","volume":"14","author":"Turner","year":"1997","journal-title":"Sarcoidosis"},{"key":"2024102404005680000_31.163.210165.45","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/ajg.2017.231","article-title":"Clinical characteristics and outcome of hepatic sarcoidosis: a population-based study 1976\u20132013","volume":"112","author":"Ungprasert","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2024102404005680000_31.163.210165.46","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.5.615"},{"key":"2024102404005680000_31.163.210165.47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fmed.2019.00232","article-title":"Hepatic sarcoidosis: natural history and management implications","volume":"6","author":"Sedki","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"2024102404005680000_31.163.210165.48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MEG.0b013e32834c7b71","article-title":"Liver-test abnormalities in sarcoidosis","volume":"24","author":"Cremers","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2024102404005680000_31.163.210165.49","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.semarthrit.2018.10.010","article-title":"Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension","volume":"48","author":"Young","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2024102404005680000_31.163.210165.50","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"2024102404005680000_31.163.210165.51","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024102404005680000_31.163.210165.52","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03358-2020"},{"key":"2024102404005680000_31.163.210165.53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rmed.2019.09.001","article-title":"Mortality for sarcoidosis patients on the transplant wait list in the Lung Allocation Score era: experience from a high volume center","volume":"157","author":"Gangemi","year":"2019","journal-title":"Respir Med"},{"key":"2024102404005680000_31.163.210165.54","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2822"},{"key":"2024102404005680000_31.163.210165.55","first-page":"317","article-title":"The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis","volume":"33","author":"Mirsaeidi","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12471-016-0847-1","article-title":"Pulmonary hypertension complicating pulmonary sarcoidosis","volume":"24","author":"Huitema","year":"2016","journal-title":"Neth Heart J"},{"key":"2024102404005680000_31.163.210165.57","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1876"},{"key":"2024102404005680000_31.163.210165.58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102404005680000_31.163.210165.59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-877OC"},{"key":"2024102404005680000_31.163.210165.60","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01319-2015"},{"key":"2024102404005680000_31.163.210165.61","doi-asserted-by":"publisher","DOI":"10.1097\/00005382-199910000-00007"},{"key":"2024102404005680000_31.163.210165.62","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.1.30"},{"key":"2024102404005680000_31.163.210165.63","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/echo.13163","article-title":"Right heart involvement in patients with sarcoidosis","volume":"33","author":"Patel","year":"2016","journal-title":"Echocardiography"},{"key":"2024102404005680000_31.163.210165.64","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200210-1130OC"},{"key":"2024102404005680000_31.163.210165.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.03.022"},{"key":"2024102404005680000_31.163.210165.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.12.011"},{"key":"2024102404005680000_31.163.210165.67","first-page":"281","article-title":"Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis","volume":"33","author":"Condado","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.68","doi-asserted-by":"crossref","first-page":"100616","DOI":"10.1016\/j.cpcardiol.2020.100616","article-title":"Characteristics and outcomes of pulmonary angioplasty with or without stenting for sarcoidosis-associated pulmonary hypertension: systematic review and individual participant data meta-analysis","volume":"46","author":"daSilva-deAbreu","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"2024102404005680000_31.163.210165.69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01914-2018"},{"key":"2024102404005680000_31.163.210165.70","first-page":"A1828","article-title":"Riociguat was effective in increasing time until clinical worsening in sarcoidosis-associated pulmonary hypertension: results of a one year double blind, placebo controlled trial","volume":"203","author":"Baughman","year":"2021","journal-title":"Am J Resp Crit Care Med"},{"key":"2024102404005680000_31.163.210165.71","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1766"},{"key":"2024102404005680000_31.163.210165.72","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.73","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1086\/688775","article-title":"Tadalafil therapy for sarcoidosis-associated pulmonary hypertension","volume":"6","author":"Ford","year":"2016","journal-title":"Pulm Circ"},{"key":"2024102404005680000_31.163.210165.75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687"},{"key":"2024102404005680000_31.163.210165.76","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-8-200810210-00004"},{"key":"2024102404005680000_31.163.210165.77","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1881"},{"key":"2024102404005680000_31.163.210165.78","first-page":"184","article-title":"Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension","volume":"37","author":"Abston","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102404005680000_31.163.210165.79","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1481"},{"key":"2024102404005680000_31.163.210165.80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"2024102404005680000_31.163.210165.81","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207497"},{"key":"2024102404005680000_31.163.210165.82","first-page":"74","article-title":"Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series","volume":"37","author":"Mathijssen","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0165-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:04:49Z","timestamp":1740373489000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0165-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":82,"journal-issue":{"issue":"163","published-online":{"date-parts":[[2022,2,9]]},"published-print":{"date-parts":[[2022,3,31]]}},"alternative-id":["10.1183\/16000617.0165-2021"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0165-2021","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}